Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantumzyme (QTZM) Liabilities and Shareholders Equity (2016 - 2026)

Quantumzyme (QTZM) has 5 years of Liabilities and Shareholders Equity data on record, last reported at $184.0 in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity changed N/A year-over-year to $184.0; the TTM value through Oct 2025 reached $1352.0, down 94.77%, while the annual FY2025 figure was $584.0, 94.16% down from the prior year.
  • Liabilities and Shareholders Equity reached $184.0 in Q4 2025 per QTZM's latest filing, down from $584.0 in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $10000.0 in Q3 2024 and bottomed at $184.0 in Q4 2025.